Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a

[1]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  V. Budhram-Mahadeo,et al.  Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. , 2005, Cancer research.

[3]  D. Isenberg,et al.  Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90. , 2005, Arthritis and rheumatism.

[4]  D. Latchman,et al.  Coexpression of Brn‐3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis , 2004, Journal of neuroscience research.

[5]  D. Latchman,et al.  The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1 , 2004, Oncogene.

[6]  A. Singer,et al.  Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia. , 2003, Gynecologic oncology.

[7]  D. Latchman,et al.  The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo , 2001, Oncogene.

[8]  C. Woodman,et al.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study , 2001, The Lancet.

[9]  A. Miller.  Natural history of cervical human papillomavirus infections , 2001, The Lancet.

[10]  T. Rohan,et al.  Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. , 2000, The Journal of general virology.

[11]  C. Wheeler,et al.  Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. , 2000, The Journal of general virology.

[12]  J. Best,et al.  Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. , 2000, The Journal of general virology.

[13]  A. Singer,et al.  Widespread elevated expression of the human papilloma virus (HPV)-activating cellular transcription factor Brn-3a in the cervix of women with CIN3 (cervical intraepithelial neoplasia stage 3). , 2000, Clinical science.

[14]  D. Latchman,et al.  The Brn-3a Transcription Factor Plays a Critical Role in Regulating Human Papilloma Virus Gene Expression and Determining the Growth Characteristics of Cervical Cancer Cells* , 1999, The Journal of Biological Chemistry.

[15]  C. Meijer,et al.  Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study , 1999, The Lancet.

[16]  A. Singer,et al.  The HPV-activating cellular transcription factor Brn-3a is overexpressed in CIN3 cervical lesions. , 1998, The Journal of clinical investigation.

[17]  R. Burk,et al.  Natural history of cervicovaginal papillomavirus infection in young women , 1998 .

[18]  M. Rosenfeld,et al.  POU domain family values: flexibility, partnerships, and developmental codes. , 1997, Genes & development.

[19]  D. Hanahan,et al.  A transition in transcriptional activation by the glucocorticoid and retinoic acid receptors at the tumor stage of dermal fibrosarcoma development. , 1995, The EMBO journal.

[20]  D. Latchman,et al.  The opposite and antagonistic effects of the closely related POU family transcription factors Brn-3a and Brn-3b on the activity of a target promoter are dependent on differences in the POU domain , 1994, Molecular and cellular biology.

[21]  S Wacholder,et al.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. , 1993, Journal of the National Cancer Institute.

[22]  C. Verrijzer,et al.  POU domain transcription factors. , 1993, Biochimica et biophysica acta.

[23]  D. Latchman,et al.  A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. , 1992, Nucleic acids research.

[24]  D. Latchman,et al.  The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer. , 1991, Nucleic acids research.

[25]  H. Nakshatri,et al.  Ubiquitous and cell-type-specific protein interactions with human papillomavirus type 16 and type 18 enhancers. , 1990, Virology.

[26]  H. Bernard,et al.  Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. , 1990, Nucleic acids research.

[27]  H. Bernard,et al.  Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia , 1989, Journal of virology.

[28]  L. Swanson,et al.  Expression of a large family of POU-domain regulatory genes in mammalian brain development , 1989, Nature.

[29]  E. Winnacker,et al.  Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. , 1989, Nucleic acids research.

[30]  L. Turek,et al.  Transcriptional regulation of the human papillomavirus‐16 E6‐E7 promoter by a keratinocyte‐dependent enhancer, and by viral E2 trans‐activator and repressor gene products: implications for cervical carcinogenesis. , 1987, The EMBO journal.

[31]  H. Wesch,et al.  HUMAN PAPILLOMAVIRUS INFECTIONS IN WOMEN WITH AND WITHOUT ABNORMAL CERVICAL CYTOLOGY , 1987, The Lancet.

[32]  N. Maitland,et al.  HUMAN PAPILLOMAVIRUS TYPE-16 HOMOLOGOUS DNA IN NORMAL HUMAN ECTOCERVIX , 1986, The Lancet.

[33]  E. Burghardt.  Microinvasive carcinoma in gynaecological pathology. , 1984, Clinics in obstetrics and gynaecology.

[34]  L. Gissmann,et al.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Calvin G. Barnes,et al.  Arthritis and Rheumatism , 1966, The British journal of clinical practice.

[36]  D. Smithers,et al.  Cancer Research , 1972, Nature.

[37]  V. Georgiev.  Virology , 1955, Nature.